: Omicron subvariant XBB.1.5 accounts for nearly 90% new Covid cases in US #IndiaNEWS #Education Washington, March 4 (IANS) The highly transmissible Omicron subvariant XBB.1.5 now accounts for nearly
Omicron subvariant XBB.1.5 accounts for nearly 90% new Covid cases in US #IndiaNEWS #Education
Washington, March 4 (IANS) The highly transmissible Omicron subvariant XBB.1.5 now accounts for nearly 90 per cent of all Covid-19 cases reported in the US, according to the latest estimates by the Centers for Disease Control and Prevention (CDC).
The prevalence of XBB.1.5 has kept increasing since late last year, and it is estimated to account for 89.2 per cent of new Covid-19 cases in the country this week, up from 85.4 per cent last week and 79.7 per cent two weeks prior, reports Xinhua news agency.
The second most prevalent strain BQ.1.1 accounts for 6.7 per cent.
The CDC first started tracking XBB.1.5 in November last year, when it accounted for less than 1 per cent of cases nationwide.
Since then, the strain is spreading quickly in the US.
Early study suggests XBB.1.5 has a couple of concerning mutations that suggest it is even more contagious than other strains, possibly the most transmissible one so far.
While XBB.1.5 is spreading easier, scientists said it does not seem to cause more severe disease.
IANS
ksk/
Stock Market NEWS Best intraday tips Intraday Stocks below 100
0 Reactions React
More posts by @IndiaNEWS
: WPL 2023 marks the start of chance to shine for talented Indian domestic players #IndiaNEWS #Sports The idea behind the promo is crystal clear cricketers have been household names in India for a
0 Reactions React
: WPL 2023: What is the financial security? Even if you win, who would recognise you? recalls Reema Malhotra #IndiaNEWS #Sports I once said to a players father, uncle, theres womens cricket, please
0 Reactions React
0 Comments
Sorted by latest first Latest Oldest Best
Terms of Use Create Support ticket Your support tickets Powered by ePowerPress Stock Market News! Top Seo SMO © hashkaro.com2024 All Rights reserved.